The latest announcement is out from Zomedica ( (ZOMDF) ).
On April 25, 2025, Scott Jordan resigned as Chief Financial Officer of Zomedica Corp. and its subsidiary, Zomedica Inc., to return to his consulting firm, S. Jordan Associates. In his absence, Michael Zuehlke, Vice President of Finance and Corporate Controller, will manage the company’s accounting and finance operations until a new CFO is appointed. The resignation and transition are managed under a separation agreement that includes salary continuation and other terms.
Spark’s Take on ZOMDF Stock
According to Spark, TipRanks’ AI Analyst, ZOMDF is a Neutral.
Zomedica’s stock score reflects mixed financial performance with revenue growth but persistent profitability challenges. The technical analysis shows weak momentum, and the valuation is impacted by a negative P/E ratio. Despite strong earnings call highlights, increased net loss and delisting risks present concerns.
To see Spark’s full report on ZOMDF stock, click here.
More about Zomedica
Zomedica Corp. operates in the veterinary health industry, focusing on providing diagnostic and therapeutic products for companion animals. The company aims to enhance the quality of care for pets by offering innovative solutions to veterinarians.
YTD Price Performance: -62.14%
Average Trading Volume: 6,443,256
Technical Sentiment Signal: Buy
Current Market Cap: $52.23M
For an in-depth examination of ZOMDF stock, go to TipRanks’ Stock Analysis page.